On June 21, 2023, Nicholas Haft resigned from the Board of Directors of Finch Therapeutics Group, Inc., effective as of June 23, 2023. Mr. Haftâs decision to resign as a member of the Board was not the result of any disagreement between Mr. Haft and the Company on any matters relating to the Companyâs operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | -0.99% | -12.61% | -44.32% |
1st Jan change | Capi. | |
---|---|---|
-44.32% | 3.23M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- FNCH Stock
- News Finch Therapeutics Group, Inc.
- Finch Therapeutics Group, Inc. Announces Resignation of Nicholas Haft as Member of Board